U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07389044) titled 'A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis' on Jan. 16.
Brief Summary: This study will examine the safety and tolerability of single and multiple doses of IB-001, and will be conducted in two parts:
Part A: SAD study in approximately 60 Healthy Volunteer (HV). Part B: MAD study in approximately 30 adult participants living with Chronic Hepatitis B (CHB).
Study Start Date: March 04
Study Type: INTERVENTIONAL
Condition:
Chronic Hepatitis B Virus Infection
Intervention:
DRUG: IB-001
Subcutaneous (SC) injectable formulation; single ascending dose in HVs (Part A) and multipl...